The number of people in the Philadelphia region working in jobs related to cell and gene therapy has increased by 127% since 2019, according to Philadelphia-based consulting firm Econsult Solutions Inc.’s workforce analysis.
According to the study, in 2022 nearly 10,500 people in the Philadelphia area work at cell and gene therapy companies or at contract manufacturing organizations, biopharma companies, research organizations, or research hospitals in the cell and gene therapy fields.
The study predicts that this growth will continue in years to come and projects minimum employment growth of between 25% and 50% in the cell and gene therapy field over the next three years.
“We have an enormous opportunity here to continue building a talent pipeline that reflects inclusive growth and prosperity,” said Saul Behar, general counsel and senior vice president of strategic initiatives for the University City Science Center.
Read the full story here.